John Mulligan

Chief Executive Officer at Bonum Therapeutics.

Earliest Form D on file: Apr 2026

Filed Apr 17, 2026

Bonum Therapeutics

Cytokine therapies that switch on only at their target

Biotech, Seattle WA

Signed as Chief Executive Officer

$26.9M

sold of $32.3M offered

Network

At Bonum Therapeutics

10 people

Diane Hollenbaugh
Executive Officer
Gaurav Aggarwal
Director
John McKearn
Director
Karl Handelsman
Director
Mitchell Mutz
Director
Monique Schiersing
Director

4 more at Bonum Therapeutics